The clinical aspects ot the sulphonylurea compounds from the position of the cardioprotective approach at patient with type 2 diabetes, using glucocardiomonitoring
BACKGRAUND: Now the trend of Type 2 Diabetes Mellitus (T2DM) management from glucocentric to cardioprotective approach take place, and it especially relevant for the multiple group of patients with T2DM using Sulphonylurea (SU). Meanwhile the synchronized glucocardiomonitoring allowed to providing t...
Main Authors: | N. A. Chernikova, L. L. Kamynina, A. S. Аmetov, D. A. Sychov |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2022-10-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/12902 |
Similar Items
-
Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model
by: Marianne Berdugo, et al.
Published: (2021-07-01) -
Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: A multicenter cross‐sectional study
by: Atsuko Matsuoka, et al.
Published: (2020-03-01) -
Recurrent and persistent hypoglycemia following intoxication
with glibenclamide overdose: case report
Published: (2021-08-01) -
Ubiquitous cardiology : emerging wireless telemedical applications /
by: Augustyniak, Piotr, 1965-, et al.
Published: (c200) -
EFFICANCY OF GLIBENCLAMIDE FOR THE CONTROL OF GESTATIONAL DIABETES MELLITUS
by: Quddsia Tanveer, et al.
Published: (2015-03-01)